Kimberly A Forde

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. pmc Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
    K A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    J Viral Hepat 19:271-7. 2012
  2. pmc Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, 3400 Spruce Street, 3 Ravdin, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 7:1121-6. 2009
  3. pmc Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system
    David S Goldberg
    Division of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania Electronic address
    Gastroenterology 148:1353-61.e3. 2015
  4. pmc No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease
    Mark T Osterman
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 9:875-80. 2011
  5. pmc Factors that predict short-term intensive care unit mortality in patients with cirrhosis
    Ranjeeta Bahirwani
    Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 11:1194-1200.e2. 2013
  6. pmc Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:861-72. 2013
  7. doi request reprint Cancer incidence in The Health Improvement Network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:730-6. 2009
  8. pmc Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans
    David S Goldberg
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia3Leonard Davis Institute of Healt
    JAMA 311:1234-43. 2014
  9. pmc End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease
    Ranjeeta Bahirwani
    Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Clin Transplant 28:205-10. 2014
  10. pmc Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection
    Zina Meriden
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 8:289-96, 296.e1-8. 2010

Collaborators

Detail Information

Publications17

  1. pmc Risk of myocardial infarction associated with chronic hepatitis C virus infection: a population-based cohort study
    K A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19104, USA
    J Viral Hepat 19:271-7. 2012
    ..16; 95% CI, 0.77-1.74). In conclusion, HCV infection was not associated with an increased risk of incident MI...
  2. pmc Racial and ethnic differences in presentation, etiology, and outcomes of acute liver failure in the United States
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, 3400 Spruce Street, 3 Ravdin, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 7:1121-6. 2009
    ..In patients with chronic liver disease, race plays a role in the rate of survival after transplantation. It is not known how race and ethnicity influence the presentation, etiology, and outcomes in patients with acute liver failure (ALF)...
  3. pmc Population-representative incidence of drug-induced acute liver failure based on an analysis of an integrated health care system
    David S Goldberg
    Division of Gastroenterology, University of Pennsylvania, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, Pennsylvania Center for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia, Pennsylvania Electronic address
    Gastroenterology 148:1353-61.e3. 2015
    ..We aimed to determine the incidence and outcomes of drug-induced ALF in an integrated health care system that approximates a population-based cohort...
  4. pmc No increased risk of myocardial infarction among patients with ulcerative colitis or Crohn's disease
    Mark T Osterman
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 9:875-80. 2011
    ..We aimed to determine the risk of first-time acute MI in patients with ulcerative colitis (UC) or Crohn's disease (CD) compared with patients from general practice...
  5. pmc Factors that predict short-term intensive care unit mortality in patients with cirrhosis
    Ranjeeta Bahirwani
    Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin Gastroenterol Hepatol 11:1194-1200.e2. 2013
    ..We aimed to identify factors that predict early (7 d) mortality among patients with cirrhosis admitted to the intensive care unit (ICU) and to develop a risk-stratification model...
  6. pmc Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database
    Vincent Lo Re
    Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Pharmacoepidemiol Drug Saf 22:861-72. 2013
    ....
  7. doi request reprint Cancer incidence in The Health Improvement Network
    Kevin Haynes
    Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, PA 19104 6021, USA
    Pharmacoepidemiol Drug Saf 18:730-6. 2009
    ..This study assessed whether the recorded incidence of cancer among patients in The Health Improvement Network (THIN) database is comparable to that expected in the UK based on national cancer registry data...
  8. pmc Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans
    David S Goldberg
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia2Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia3Leonard Davis Institute of Healt
    JAMA 311:1234-43. 2014
    ..The effect of increased travel on access and outcomes from these services is not fully understood...
  9. pmc End-stage renal disease after liver transplantation in patients with pre-transplant chronic kidney disease
    Ranjeeta Bahirwani
    Division of Gastroenterology and Hepatology, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    Clin Transplant 28:205-10. 2014
    ..Renal dysfunction prior to liver transplantation has a marked impact on post-transplant kidney outcomes...
  10. pmc Histologic predictors of fibrosis progression in liver allografts in patients with hepatitis C virus infection
    Zina Meriden
    Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin Gastroenterol Hepatol 8:289-96, 296.e1-8. 2010
    ..Recurrent hepatitis C with ensuing fibrosis is the leading cause of liver allograft loss. We investigated whether histologic features in early posttransplant liver biopsies could predict the rate of fibrosis progression in this population...
  11. doi request reprint Immunosuppressant medications and mortality in inflammatory bowel disease
    James D Lewis
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Am J Gastroenterol 103:1428-35; quiz 1436. 2008
    ..This study examined whether treatment of Crohn's disease (CD) and ulcerative colitis (UC) with immunosuppressant medications was associated with an increased risk of death in the era prior to antitumor necrosis factor (TNF) therapies...
  12. pmc Do statins reduce hepatitis C RNA titers during routine clinical use?
    Kimberly A Forde
    Research Section, Philadelphia Veterans Administration Medical Center, Research A402A, 3900 Woodland Avenue, Philadelphia, PA 19104, United States
    World J Gastroenterol 15:5020-7. 2009
    ..To compare hepatitis C virus (HCV) titers in patients with chronic hepatitis C with and without exposure to 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins)...
  13. pmc Coding algorithms for identifying patients with cirrhosis and hepatitis B or C virus using administrative data
    Bolin Niu
    Department of Medicine, University of Pennsylvania, Philadelphia, PA, United States
    Pharmacoepidemiol Drug Saf 24:107-11. 2015
    ..The validation of such algorithms is necessary for future epidemiological studies...
  14. doi request reprint Comparative risk of recurrence of dysplasia and carcinoma after endoluminal eradication therapy of high-grade dysplasia versus intramucosal carcinoma in Barrett's esophagus
    Aaron J Small
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
    Gastrointest Endosc 81:1158-1166.e4. 2015
    ..Little is known about outcome differences in patients with HGD versus IMC...
  15. pmc Prevalence and risk factors for patient-reported joint pain among patients with HIV/Hepatitis C coinfection, Hepatitis C monoinfection, and HIV monoinfection
    Alexis Ogdie
    Division of Rheumatology, Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Penn Tower Room 1407, 1 Convention Ave, Philadelphia, PA 19104, USA
    BMC Musculoskelet Disord 16:93. 2015
    ....
  16. pmc Hepatitis B and C in African Americans: current status and continued challenges
    Kimberly A Forde
    Division of Gastroenterology and Hepatology, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania Center for Clinical Epidemiology and Biostatistics, Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
    Clin Gastroenterol Hepatol 12:738-48. 2014
    ..For the purposes of this review, the terms African American and black will be used interchangeably throughout the text. ..
  17. doi request reprint Hepatitis C virus infection and immunomodulatory therapies
    Kimberly A Forde
    Division of Gastroenterology, Department of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA
    Clin Liver Dis 13:391-401. 2009
    ..In this article, the authors discuss immunomodulatory therapies and clinical trials in the treatment of HCV infection...